Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies

Nephrology Dialysis Transplantation

Volumn 26, Issue 2, 2011, Pages 580-583

  Izzedine, Hassane ^a   Acharya, Veena ^b   Wirden, Marc ^a   Cluzel, Philippe ^a   Sene, Damien ^a   Lucas, Gregory M ^b   Baumelou, Alain ^a   Atta, Mohamed G ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; HIV DNA level; HIVAN; nephropathies

Indexed keywords

MARKER; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIREMIA; VIRUS LOAD;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; BIOLOGICAL MARKERS; BIOPSY; DNA, VIRAL; FEMALE; HIV-1; HUMANS; KIDNEY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROVIRUSES; VIRAL LOAD;

EID: 79551488427     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq414     Document Type: Article

References (15)

1. Izzedine H, Wirden M, Launay-Vacher VN. Viral load and HIVassociated nephropathy. N Engl J Med 2005; 353: 1072-1074
2. Goujard C, Bonarek M, Meyer L et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006; 42: 709-715
3. Hatzakis AE, Touloumi G, Pantazis N et al. Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS 2004; 18: 2261-2267
4. Rozera G, Abbate I, Bruselles A et al. Comparison of real-time PCR methods for measurement of HIV-1 proviral DNA. J Virol Meth 2010; 164: 135-138
5. Zhong J, Zuo Y, Ma J et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005; 68: 1048-1060
6. Bieche I, Olivi M, Champeme MH et al. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998; 78: 661-666
7. Viard JP, Burgard M, Hubert JB et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 2004; 18: 45-49
8. Sarmati L, Parisi SG, Nicastri E et al. Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy. J Clin Microbiol 2005; 43: 6183-6185
9. Coste J, Montes B, Reynes J et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996; 50: 293-302
10. Chun TW, Stuyver L, Mizell SB et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997; 94: 13193-13197
11. Finzi D, Blankson J, Siliciano JD et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999; 5: 512-517
12. Gibellini D, Vitone F, Schiavone P et al. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol 2004; 29: 282-289 (Pubitemid 38281220)
13. Cohen AH, Sun NC, Shapshak P et al. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 1989; 2: 125-128
14. Bruggeman LA, Ross MD, Tanji N et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11: 2079-2087
15. Estrella M, Fine DM, Gallant JE et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis 2006; 43: 377-380